Division of Rheumatology

We are devoted to delivering the highest standard of clinical care to all with rheumatic diseases. We strive for excellence in clinical, teaching and research activities.

Head of Division Prof. Lai-Shan Tam, Chair Professor
Academic Staff and Clinical Staff Prof. Edmund K Li, Clinical Professor (Honorary)
Prof. Ho So, Assistant Professor
Dr. Kong-Chiu Wong, Consultant
Dr. Lydia HP Tam, Associate Consultant
Dr. Jacqueline So, Associate Consultant
Dr. Tommy Lam, Specialist
Dr. Edmund Wong, Specialist
Research Staff Dr. Martin Li
Dr. Isaac TH Cheng
Dr. Huan Meng
Dr. Yingzhao Jin
Xerox SL Lau
Victor Tam
Cheryl Chung
Peter Shek
Nursing Staff Kathy Tin
Karin Mo
WO Li
Tracey WK Yu

Our Facebook / Instagram page
Contact us: rheumatology@cuhk.edu.hk

Research Interests

  • Long term structural outcomes of patients with inflammatory arthritis including rheumatoid arthritis (RA), psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA)
  • Premature atherosclerosis in patients with rheumatic diseases
  • Inflammation and glucocorticoid induced bone loss (GIOP) in patients with rheumatic diseases
  • Pathogenesis of SLE
  • Disease burden and comorbidities in patients with rheumatic disease using city-wide big data approach

Selected Publications

  1. Tam LS, et al. Subclinical Carotid Atherosclerosis in Patients with Psoriatic Arthritis. Arthritis Rheum 2008; 59:1322–1331.
  2. Tam LS, Gu J, Yu D. Pathogenesis of ankylosing spondylitis. Nat Rev Rheumatol 2010 Jul;6(7):399-405.
  3. Tam LS, et al. TNF-a blockade is associated with sustained regression of carotid intima-media thickness for patients with active psoriatic arthritis-a 2-year pilot study. Ann Rheum Dis 2011;70:705-706.
  4. Rainer TH, Cheng CH, Janssens HJ, Man CY, Tam LS et al. Oral Prednisolone in the Treatment of Acute Gout: A Pragmatic, Multi-center, Double-Blind, Randomized Trial. Ann Int Med 2016;164(7):464-471.
  5. Shen J, Wong KT, Cheng IT, Shang Q, PhD, Li EK, Wong P, Kun EW, Law MY, Yip R, Yim I, Ying S, Li M, Li TK, Wong CK, Zhu TY, PhD, Lee JJ, Chang M, Lee AP, Tam LS. Increased prevalence of coronary plaque in patients with psoriatic arthritis without prior diagnosis of coronary artery disease. Ann Rheum Dis 2017 76(7):1237-1244.
  6. Cheng IT, Shang Q, Li EK, Wong PC, Kun EW, Law MY, Yip RM, FRCP, Yim IC, Lai BT, FRCP, Ying SK, Kwok KY, FHKAM, Li M, PhD, Li TK, Zhu TY, Lee JJ, Chang MM, Szeto CC, MD, Yan BP, Lee AP, Tam LS. Can achieving Minimal Disease Activity prevent progression of subclinical atherosclerosis and arterial stiffness? A prospective cohort study in Psoriatic Arthritis. Arthritis Rheumatol 2019;71:271-280
  7. Lam SH, Cheng IT, Li EK, Wong P, Lee J, Yip RM, et al. DAPSA, carotid plaque and cardiovascular events in psoriatic arthritis: a longitudinal study. Ann Rheum Dis. 2020;79:1320-1326.
  8. So H, Cheng IT, Lau SL, Chow E, Lam T, Hung VW, et al. Effects of RANKL inhibition on promoting healing of bone erosion in rheumatoid arthritis using HR-pQCT: a 2-year, randomised, double-blind, placebo-controlled trial. Ann Rheum Dis. 2021;80:981-988.
  9. So H, So J, Lam TT, Wong VT, Ho R, Li WL, Lau CS, Tam LS. Performance of the 2017 EULAR/ACR classification criteria in anti-MDA5 associated idiopathic inflammatory myopathy. Arthritis Rheumatol 2022, Sep;74(9):1588-1592
  10. Jin Y, Cheng IT, So H, Lai BT, Ying SK, Kwok KY, et al. Effects of secukinumab on enthesiophyte and erosion progression in psoriatic arthritis -a one-year double-blind, randomized, placebo-controlled trial utilizing high-resolution peripheral quantitative computed tomography. Arthritis Rheumatol. 2025 Mar 14. doi: 10.1002/art.43154.